LIXT
Lixte Biotechnology Holdings Inc

3,604
Loading...
Loading...
Lixte Biotechnology Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of developing a drug class called protein phosphatase 2A inhibitors. The firm is also involved in utilizing biomarker technology to identify enzyme targets associated with serious common diseases and then designing novel compounds to attack those targets. The company was founded by John S. Kovach and Robert B. Royds on May 24, 2005 and is headquartered in Pasadena, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
2

Frequently Asked Questions

What is Market Cap of Lixte Biotechnology Holdings Inc?
What is the 52-week high for Lixte Biotechnology Holdings Inc?
What is the 52-week low for Lixte Biotechnology Holdings Inc?
What is Lixte Biotechnology Holdings Inc stock price today?
What was Lixte Biotechnology Holdings Inc stock price yesterday?
What is the PE ratio of Lixte Biotechnology Holdings Inc?
What is the Price-to-Book ratio of Lixte Biotechnology Holdings Inc?
What is the 50-day moving average of Lixte Biotechnology Holdings Inc?
How many employess does Lixte Biotechnology Holdings Inc has?

Latest LIXT News

View

Advertisement. Remove ads.

Advertisement. Remove ads.